The development of cell and gene therapies (CGT), involves the cultivation of cells and the expression of genes in a controlled environment. Glass bioreactors are an essential product for this development. At Shanghai Ritai, we understand the intricacies involved in CGT development and engineer glass bioreactors suited to the situation. Our bioreactors have cutting-edge monitoring systems that allow conditions to be adjusted in real-time and guarantee optimum cell productivity and viability. Considering our experience in biopharma, we offer full lifecycle support that increases productivity and regulatory adherence.
Copyright © 2026 by Shanghai Ritai Medicine Equipment Project Co., Ltd. - Privacy policy